ME-1111 | Interleukin Related interleukin-related.com

Product Name :
ME-1111

Search keywords :
ME1111

drugId :
null

Target Vo:
Mitochondrial complex II; succinate dehydrogenase

Target Vo Short Name :
SDH2

Moa_Name:
Mitochondrial complex II; succinate dehydrogenase inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Meiji Seika Pharma

Active Company_Name :

Active Indication_Name:

In Active Indication_Name:
Onychomycosis

Termination Status :
Phase 2 Clinical

China Termination Status :

Highest Status:
Pending

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Pagibaximab supplier
Nrf2 Antibody(YA895) Technical Information
C3 Antibody: C3 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 187 kDa, targeting to C3. It can be used for WB,IHC-P assays with tag free, in the background of Human.

Author: Interleukin Related

Related Posts